Multi-Dimensional Structural Fingerprinting for Quantitative Polymorph Comparison: A Comprehensive Topological Analysis of Sulfathiazole, Galunisertib and Aripiprazole Polymorphs
This paper introduces a robust, unit-cell-independent multi-dimensional topological fingerprinting framework that quantitatively compares organic crystal polymorphs across five structural categories, demonstrating its effectiveness in classifying and ranking sulfathiazole, galunisertib, and aripiprazole forms with superior correlation to COMPACK cluster matching compared to existing invariant descriptors.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the world of solid materials, a single chemical substance can exist in more than one way. Just as a set of bricks can be stacked to build a wall, a tower, or a bridge, the same molecules can arrange themselves into different three-dimensional patterns when they crystallize. These different arrangements are called polymorphs. While the chemical recipe remains identical, the physical structure changes, and with it, the material's behavior. For medicines, this difference is critical; one arrangement might dissolve quickly in the body to cure an illness, while another might remain inert, or worse, become unstable and lose its potency. Pharmaceutical companies must identify and control every possible form a drug can take, but telling these subtle variations apart is notoriously difficult. Traditional methods often rely on comparing the patterns of X-rays bouncing off the crystals, which can be like trying to identify a person by their shadow: it gives a clue, but it misses the details of the face.
A team of researchers has developed a new way to look inside these crystal structures, moving beyond simple shadows to measure the actual relationships between molecules. Instead of asking if two crystals look the same, their method asks how they are different and in exactly which ways. By breaking a crystal down into five distinct layers of organization—how the molecules pack together, how they touch and bond, how they twist and bend, how their parts are oriented, and how they are spaced in 3D space—they created a detailed "fingerprint" for each form. This approach was tested on three different drug molecules: sulfathiazole, an antibiotic; galunisertib, a cancer treatment; and aripiprazole, an antipsychotic. The researchers found that while some aspects of a crystal's structure remain stubbornly consistent across different forms, others change dramatically, and the specific pattern of change depends entirely on the molecule itself.
The core of this new method is a shift in perspective. Rather than trying to force two crystal structures to line up perfectly, which often fails when the molecules have twisted into different shapes, the researchers treated the crystal as a collection of repeating patterns. They examined the entire crystal, not just a small snapshot, and measured the distances and angles between molecules in a way that does not depend on how the crystal was oriented in space or how it was labeled in a database. This ensures that the comparison is fair and consistent, regardless of who measured it or where it was stored. The team then compared these measurements using a mathematical tool that calculates the "work" required to turn one distribution of distances into another, providing a precise score of similarity.
When applied to sulfathiazole, which has five known forms, the method revealed that the spatial arrangement of the molecules—their neighbors and how they are spaced—was the most consistent feature across all forms. However, the way the molecules themselves twisted and the specific patterns of their hydrogen bonds varied enough to clearly separate the forms into two distinct groups. This matched what other established methods had found, but the new approach explained why they were different, breaking the similarity down into its component parts. For the cancer drug galunisertib, which has ten different forms, the story was different. Here, the internal shape of the molecule and the spatial arrangement were the most stable features, while the way the molecules packed together and bonded changed the most. This high degree of variety made it difficult for older methods to tell the forms apart, but the new fingerprinting technique successfully navigated the complexity, identifying subtle differences that other tools missed.
The most challenging test came with aripiprazole, a flexible drug molecule that can twist and turn in many ways. In this case, the spatial arrangement of the molecules was the least consistent feature, varying wildly between forms. The method successfully distinguished between forms that shared the same packing but had different molecular shapes, and those that shared the same shape but were packed differently. This ability to separate "packing polymorphs" from "conformational polymorphs" is a significant advance, as it allows scientists to understand exactly what is changing when a drug shifts from one form to another. The researchers confirmed that their method is robust, meaning it gives the same results even if the atomic positions are slightly shifted by experimental noise, and it is fast enough to screen thousands of structures in seconds.
By providing a clear, multi-dimensional map of how crystal structures relate to one another, this work offers a powerful new tool for the pharmaceutical industry. It does not replace the need to understand a drug's stability or how well it dissolves, but it provides a fast and reliable way to flag new forms that are structurally distinct from known ones. The study demonstrates that by looking at crystals through multiple lenses simultaneously, scientists can move past vague similarities and see the precise structural relationships that define a material. This clarity is essential for ensuring that medicines are safe, effective, and consistent, turning the complex puzzle of crystal forms into a solvable problem.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.